Real-World Retrospective Study into the Effects of Oral Semaglutide (As a Switchover or Add-On Therapy) in Type 2 Diabetes

(1) Background: Oral semaglutide represents the first oral GLP-1 RA approved for the treatment of type 2 diabetes mellitus (T2DM). This real-world retrospective study aimed at evaluating its effectiveness and tolerability in the treatment of patients with T2DM when patients switched from a glucose-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Candido, Riccardo, Gaiotti, Sara, Giudici, Fabiola, Toffoli, Barbara, De Luca, Federica, Velardi, Valerio, Petrucco, Alessandra, Gottardi, Chiara, Manca, Elena, Buda, Iris, Fabris, Bruno, Bernardi, Stella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532177/
https://www.ncbi.nlm.nih.gov/pubmed/37762991
http://dx.doi.org/10.3390/jcm12186052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532177/
https://www.ncbi.nlm.nih.gov/pubmed/37762991
http://dx.doi.org/10.3390/jcm12186052

Ejemplares similares